pearsons chi-squared method Search Results


pearson chi-square method  (CH Instruments)
90
CH Instruments pearson chi-square method
Antiplatelet antibody results in HCV-TP patients, HBV-TP patients, and HCV controls. A. Antiplatelet antibody profiles. Compared with HCV controls, HCV-TP patients had significantly higher positive rates for antiplatelet antibody and HLA class I antibody. ∗ denotes statistical significance compared with HCV controls. B. Antiplatelet antibody complexity. The results revealed the number of types of antiplatelet antibodies. Significant differences were observed between HCV-TP patients and HCV controls ( p = 0.024) but not between HCV-TP and HBV-TP groups using the <t>Pearson</t> chi-square method.
Pearson Chi Square Method, supplied by CH Instruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pearsons+chi-squared+method/pmc09661505-182-29-30?v=CH+Instruments
Average 90 stars, based on 1 article reviews
pearson chi-square method - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
pearson chi-square scale parameter method  (CH Instruments)
90
CH Instruments pearson chi-square scale parameter method
Antiplatelet antibody results in HCV-TP patients, HBV-TP patients, and HCV controls. A. Antiplatelet antibody profiles. Compared with HCV controls, HCV-TP patients had significantly higher positive rates for antiplatelet antibody and HLA class I antibody. ∗ denotes statistical significance compared with HCV controls. B. Antiplatelet antibody complexity. The results revealed the number of types of antiplatelet antibodies. Significant differences were observed between HCV-TP patients and HCV controls ( p = 0.024) but not between HCV-TP and HBV-TP groups using the <t>Pearson</t> chi-square method.
Pearson Chi Square Scale Parameter Method, supplied by CH Instruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pearsons+chi-squared+method/pm28411561-131-39-40?v=CH+Instruments
Average 90 stars, based on 1 article reviews
pearson chi-square scale parameter method - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
asymmetric two-tailed pearson chi-square method  (CH Instruments)
90
CH Instruments asymmetric two-tailed pearson chi-square method
Antiplatelet antibody results in HCV-TP patients, HBV-TP patients, and HCV controls. A. Antiplatelet antibody profiles. Compared with HCV controls, HCV-TP patients had significantly higher positive rates for antiplatelet antibody and HLA class I antibody. ∗ denotes statistical significance compared with HCV controls. B. Antiplatelet antibody complexity. The results revealed the number of types of antiplatelet antibodies. Significant differences were observed between HCV-TP patients and HCV controls ( p = 0.024) but not between HCV-TP and HBV-TP groups using the <t>Pearson</t> chi-square method.
Asymmetric Two Tailed Pearson Chi Square Method, supplied by CH Instruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pearsons+chi-squared+method/pmc04422545-187-32-33?v=CH+Instruments
Average 90 stars, based on 1 article reviews
asymmetric two-tailed pearson chi-square method - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
pearson chi-square test with z-test with adjusted p-values (bonferroni method)  (CH Instruments)
90
CH Instruments pearson chi-square test with z-test with adjusted p-values (bonferroni method)
Antiplatelet antibody results in HCV-TP patients, HBV-TP patients, and HCV controls. A. Antiplatelet antibody profiles. Compared with HCV controls, HCV-TP patients had significantly higher positive rates for antiplatelet antibody and HLA class I antibody. ∗ denotes statistical significance compared with HCV controls. B. Antiplatelet antibody complexity. The results revealed the number of types of antiplatelet antibodies. Significant differences were observed between HCV-TP patients and HCV controls ( p = 0.024) but not between HCV-TP and HBV-TP groups using the <t>Pearson</t> chi-square method.
Pearson Chi Square Test With Z Test With Adjusted P Values (Bonferroni Method), supplied by CH Instruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pearsons+chi-squared+method/pm30925444-93-15-9?v=CH+Instruments
Average 90 stars, based on 1 article reviews
pearson chi-square test with z-test with adjusted p-values (bonferroni method) - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
pearson’s chi-square method implemented in chifish  (CH Instruments)
90
CH Instruments pearson’s chi-square method implemented in chifish
Antiplatelet antibody results in HCV-TP patients, HBV-TP patients, and HCV controls. A. Antiplatelet antibody profiles. Compared with HCV controls, HCV-TP patients had significantly higher positive rates for antiplatelet antibody and HLA class I antibody. ∗ denotes statistical significance compared with HCV controls. B. Antiplatelet antibody complexity. The results revealed the number of types of antiplatelet antibodies. Significant differences were observed between HCV-TP patients and HCV controls ( p = 0.024) but not between HCV-TP and HBV-TP groups using the <t>Pearson</t> chi-square method.
Pearson’s Chi Square Method Implemented In Chifish, supplied by CH Instruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pearsons+chi-squared+method/10__1016_slash_j__ecss__2008__06__009-94-24-19?v=CH+Instruments
Average 90 stars, based on 1 article reviews
pearson’s chi-square method implemented in chifish - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

Image Search Results


Antiplatelet antibody results in HCV-TP patients, HBV-TP patients, and HCV controls. A. Antiplatelet antibody profiles. Compared with HCV controls, HCV-TP patients had significantly higher positive rates for antiplatelet antibody and HLA class I antibody. ∗ denotes statistical significance compared with HCV controls. B. Antiplatelet antibody complexity. The results revealed the number of types of antiplatelet antibodies. Significant differences were observed between HCV-TP patients and HCV controls ( p = 0.024) but not between HCV-TP and HBV-TP groups using the Pearson chi-square method.

Journal: Biomedical Journal

Article Title: Different impacts of common risk factors associated with thrombocytopenia in patients with hepatitis B virus and hepatitis C virus infection

doi: 10.1016/j.bj.2021.09.001

Figure Lengend Snippet: Antiplatelet antibody results in HCV-TP patients, HBV-TP patients, and HCV controls. A. Antiplatelet antibody profiles. Compared with HCV controls, HCV-TP patients had significantly higher positive rates for antiplatelet antibody and HLA class I antibody. ∗ denotes statistical significance compared with HCV controls. B. Antiplatelet antibody complexity. The results revealed the number of types of antiplatelet antibodies. Significant differences were observed between HCV-TP patients and HCV controls ( p = 0.024) but not between HCV-TP and HBV-TP groups using the Pearson chi-square method.

Article Snippet: Compared with HCV patients with platelet level 1, the patients with platelet count level 4/5 had different profiles in the number of types of antiplatelet antibodies by using the Pearson chi-square method ( p = 0.015).

Techniques:

Antiplatelet antibody results according to platelet levels in HCV patients. A. Antiplatelet antibody profile. Compared with the HCV patients with platelet count level 1 (normal), patients with platelet level 3 (moderate thrombocytopenia) had significantly higher positive rates of HLA class I antibody, while patients with platelet level 4/5 (severe thrombocytopenia) had higher positive anti-GPIb/IX antibody rates. In addition, there was a trend that positive rates of all anti-GP antibody increased as severity of thrombocytopenia progressed. B. Antiplatelet antibody complexity. Compared with HCV patients with platelet level 1, the patients with platelet count level 4/5 had different profiles in the number of types of antiplatelet antibodies by using the Pearson chi-square method ( p = 0.015). In addition, these patients had a significantly lower percentage of negative antiplatelet antibodies and a higher percentage of ≥3 types of antibodies. ∗ denotes statistical significance when comparing the HCV patients with platelet count level 1.

Journal: Biomedical Journal

Article Title: Different impacts of common risk factors associated with thrombocytopenia in patients with hepatitis B virus and hepatitis C virus infection

doi: 10.1016/j.bj.2021.09.001

Figure Lengend Snippet: Antiplatelet antibody results according to platelet levels in HCV patients. A. Antiplatelet antibody profile. Compared with the HCV patients with platelet count level 1 (normal), patients with platelet level 3 (moderate thrombocytopenia) had significantly higher positive rates of HLA class I antibody, while patients with platelet level 4/5 (severe thrombocytopenia) had higher positive anti-GPIb/IX antibody rates. In addition, there was a trend that positive rates of all anti-GP antibody increased as severity of thrombocytopenia progressed. B. Antiplatelet antibody complexity. Compared with HCV patients with platelet level 1, the patients with platelet count level 4/5 had different profiles in the number of types of antiplatelet antibodies by using the Pearson chi-square method ( p = 0.015). In addition, these patients had a significantly lower percentage of negative antiplatelet antibodies and a higher percentage of ≥3 types of antibodies. ∗ denotes statistical significance when comparing the HCV patients with platelet count level 1.

Article Snippet: Compared with HCV patients with platelet level 1, the patients with platelet count level 4/5 had different profiles in the number of types of antiplatelet antibodies by using the Pearson chi-square method ( p = 0.015).

Techniques: